The cost-effectiveness of Vancouver's supervised injection facility - Wikidata - wikimedia - TriplyDB

The cost-effectiveness of Vancouver's supervised injection facility

The cost-effectiveness of Vancouver's supervised injection facility

http://www.wikidata.org/entity/Q24657903

about

Burden of disease and cost of chronic hepatitis C infection in Canada Syringe exchange in the United States: a national level economic evaluation of hypothetical increases in investment A systematic review of modelling approaches in economic evaluations of health interventions for drug and alcohol problems Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users Supervised injection facilities in Canada: past, present, and future Public health and international drug policy.Evaluating Vancouver's supervised injection facility: data and dollars, symbols and ethics.Mitigating the heroin crisis in Baltimore, MD, USA: a cost-benefit analysis of a hypothetical supervised injection facility Acceptability and design preferences of supervised injection services among people who inject drugs in a mid-sized Canadian City A cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Ottawa, Canada Is Vancouver Canada's supervised injection facility cost-saving?Vancouver's supervised injection facility challenges Canada's drug laws.A cost-benefit/cost-effectiveness analysis of an unsanctioned supervised smoking facility in the Downtown Eastside of Vancouver, Canada.Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment.A cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Montreal, Canada Effectiveness of Methadone Maintenance Treatment in Prevention of Hepatitis C Virus Transmission among Injecting Drug Users.Supervised injection sites: prejudice should not trump evidence of benefit.HIV among injecting drug users: current epidemiology, biologic markers, respondent-driven sampling, and supervised-injection facilities.Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study.Cost-effectiveness of Methadone Maintenance Treatment in Prevention of HIV Among Drug Users in Shiraz, South of Iran.The long-term effectiveness of methadone maintenance treatment in prevention of hepatitis C virus among illicit drug users: a modeling study.Cost effectiveness of hepatitis C-related interventions targeting substance users and other high-risk groups: a systematic review.Dynamic modelling of hepatitis C virus transmission among people who inject drugs: a methodological review.Behavioural, not biological, factors drive the HCV epidemic among HIV-positive MSM: HCV and HIV modelling analysis including HCV treatment-as-prevention impact.The importance of extended high viremics in models of HIV spread in South Africa.Police perceptions of supervised consumption sites (SCSs): a qualitative study.Commentary on Enns et al. (2016): Supervised injection facilities as a cost-effective intervention.Potential cost-effectiveness of supervised injection facilities in Toronto and Ottawa, Canada.Examining the potential role of a supervised injection facility in Saskatoon, Saskatchewan, to avert HIV among people who inject drugs.Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.PHArmacists' perspective oN the Take hOme naloxone prograM (The PHANTOM Study).Prospects for scaling-up supervised injection facilities in Canada: the role of evidence in legal and political decision-making.Exploring the role of an unsanctioned, supervised peer driven injection facility in reducing HIV and hepatitis C infections in people that require assistance during injection.Should we treat acute hepatitis C? A decision and cost-effectiveness analysis.The cost-effectiveness of HIV testing and treatment engagement initiatives in British Columbia, Canada: 2011-2013.Public Health and Public Order Outcomes Associated with Supervised Drug Consumption Facilities: a Systematic Review.Intervention Packages to Reduce the Impact of HIV and HCV Infections Among People Who Inject Drugs in Eastern Europe and Central Asia: A Modeling and Cost-effectiveness Study.Cost of provision of opioid substitution therapy provision in Tijuana, Mexico.Associations between herpes simplex virus type 2 and HCV With HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV Drug consumption rooms (DCRs) as a setting to address hepatitis C - findings from an international online survey

P2860

Q26849591-421DA98C-51A6-4BC5-9413-761F04E13099 Q27318250-37A8D895-54E0-465F-A123-58238FB82E14 Q28072735-E23E2D78-B50B-4E24-BAB8-947CCE02797B Q28483820-9D688079-8553-44FA-B4DC-FD193689EA61 Q30234420-4764B97A-DF27-4BD1-8A6B-BABE525844DD Q30377895-272910B7-EC39-4A5E-80E5-14111E9FF443 Q33385078-13BFB3C4-C461-423A-AB3F-83DB7680E57E Q33717043-92D9552C-5ECC-4D38-BE8B-DE326BD65A74 Q33910606-5F62F0BE-7254-4D0D-8477-E3ED965AAD9D Q34009387-0A804512-80F7-420D-A5C1-819D8EDB9FA9 Q34127630-982EA52A-9FDB-4F14-A39E-8FBE0B5367C3 Q34142633-FAC283C3-E65F-47A6-B725-5F8E8EEB74F2 Q34611579-73B6B283-A42C-452A-A287-AD259E71C690 Q35856799-93C12C5F-1656-4C99-AD63-BD37771E4EED Q37008707-ADDF78E5-1757-48CD-945A-283681B5D1EA Q37196683-BCF63578-26E0-48AE-A297-709FBB12E896 Q37229662-853E9D03-10F7-4CAB-B4E6-8B23C385E10B Q37521729-7F50EF14-25AB-4D96-824F-BFE1EED420B6 Q37655493-3B6C402D-6094-4107-8A49-398B4502EDB7 Q37660784-43C58773-3CD2-447A-9CCA-5FD0FCE7422E Q37663322-9DF1E6C3-E2B5-4F6E-A419-503C21F9FFE7 Q38050834-B94B3FF4-2914-4026-BB66-BC50BFBFA4FF Q38255693-B6A3CE86-44C3-46FA-9921-161DD1E8AB2A Q38729837-DF04C5F7-D3BD-493B-9DC9-70D7EB373D3E Q39404544-D1D252D4-40AD-49E8-A822-0DD18FD4CC71 Q39667940-7566C980-B5FE-4ED8-82FC-1007EF0D3A79 Q40351462-97556295-B7B7-4912-AE04-3828B7E7BF7C Q40891018-CDA8BE04-6478-4180-AEC4-B667462DEF13 Q41193164-979024D4-3B1B-4229-A500-22C42695855D Q42720607-8A4A2EAF-7094-424E-B1D8-EE6DE2F61D86 Q44620818-D3E1EDB4-5FFE-4001-BA52-F900E5352C42 Q45130692-9151963A-7AC0-4795-AFEE-8C463BF6F45B Q47163239-1F9980D4-56EE-438D-B818-2273261EBDDD Q47603693-D5CC33FA-E508-45A0-B44C-ED7C67965187 Q47801305-1A0E4CE2-0C3E-45C9-B0D4-9CFE543202C6 Q50217902-1C783ADB-4A13-47DA-A79A-B0CF4BCC2FFF Q52624095-B0926645-52AF-4559-82D3-FF813B3E0B64 Q55000232-27F9DF3C-8916-4CBE-A716-85FC4EB85E1C Q56961744-42784AE4-BD74-4E35-803E-B0C97FB4C74E Q57132633-46063A84-5B7E-4C81-8137-747331841DC8

P2860

The cost-effectiveness of Vancouver's supervised injection facility

http://www.wikidata.org/entity/Q24657903

description

2008 nî lūn-bûn

@nan

2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

The cost-effectiveness of Vancouver's supervised injection facility

@ast

The cost-effectiveness of Vancouver's supervised injection facility

@en

The cost-effectiveness of Vancouver's supervised injection facility

@nl

type

label

The cost-effectiveness of Vancouver's supervised injection facility

@ast

The cost-effectiveness of Vancouver's supervised injection facility

@en

The cost-effectiveness of Vancouver's supervised injection facility

@nl

prefLabel

The cost-effectiveness of Vancouver's supervised injection facility

@ast

The cost-effectiveness of Vancouver's supervised injection facility

@en

The cost-effectiveness of Vancouver's supervised injection facility

@nl

P1433

Q24657903-31D4D203-3103-4BC7-B85A-9D9AA6844B8F

P1476

Q24657903-10F86E19-280D-4C61-AF87-9183A4556A12

P2093

Q24657903-BA4B2004-4F46-4402-91F5-3DBB0137110B

Q24657903-F4687A04-B7F5-45F2-A270-C7DF19C8A9EA

P2860

Q24657903-04C42A52-B54D-4917-9611-D7FD5CF1457F

Q24657903-051B1963-C210-4A90-9D58-554AC8A6E69F

Q24657903-10FC2A3A-7E6A-45D4-ACDD-9A2F5BFD5CAB

Q24657903-15BC5402-C433-4C4C-954D-C239C494A970

Q24657903-15F2FA9D-9B1A-4F72-9CC5-15C9C400F105

Q24657903-1C9C1C22-2668-454B-AB8D-820FBD5BC336

Q24657903-204C1917-223E-4BA9-8862-7A147954AAD1

Q24657903-233A0EFF-CECD-4461-94AC-E155EAB2AE33

Q24657903-2AF2DEFD-6EC1-4315-A733-824227871ED7

Q24657903-3483D4F5-94FC-4A28-862C-5C236CCBC3BC

P304

Q24657903-A72D1D95-69C7-49F8-A3F4-17A731E82F34

P31

Q24657903-BB8FB70B-DAE6-4A09-83DB-25E904F07C2D

P3181

Q24657903-EB31CE58-764A-4613-969C-CAE704910428

P356

Q24657903-F35EFF54-43BF-4F79-85A1-781867796530

P407

Q24657903-AD542E30-887A-4E0F-A070-0B9C399FD744

P433

Q24657903-AF9E77C4-209D-4640-919E-85BC7CDD7A5B

P478

Q24657903-711C562D-582B-4F31-A2DD-9EB9A3111007

P577

Q24657903-3E77EE3D-E59B-4BE7-84A6-57092BC14D7D

P5875

Q24657903-E789854B-F098-4B09-A651-935D433C90A4

P698

Q24657903-B8CB2F8D-DDC2-466D-925E-342658AD3D70

P932

Q24657903-F9EB22ED-9139-4AF3-B966-4BB1506BBAD4

P3181

P356

P1433

Canadian Medical Association Journal

P1476

The cost-effectiveness of Vancouver's supervised injection facility

@en

P2093

Ahmed M Bayoumi

http://www.w3.org/2001/XMLSchema#string

Gregory S Zaric

http://www.w3.org/2001/XMLSchema#string

P2860

The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States

Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users

Summary of findings from the evaluation of a pilot medically supervised safer injecting facility

Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak.

Economic evaluation of interventions to treat opiate dependence : a review of the evidence.

The cost-effectiveness of methadone maintenance as a health care intervention.

A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.

Current status of hepatitis C in Canada.

Survey of drug consumption rooms: service delivery and perceived public health and amenity impact.

The direct costs of HIV/AIDS care.

P304

1143-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2338680

http://www.w3.org/2001/XMLSchema#string

P356

10.1503/CMAJ.080808

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

179

http://www.w3.org/2001/XMLSchema#string

P577

2008-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23479818

http://www.w3.org/2001/XMLSchema#string

P698

19015565

http://www.w3.org/2001/XMLSchema#string

P932

2582765

http://www.w3.org/2001/XMLSchema#string